196 related articles for article (PubMed ID: 8686975)
1. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J
Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975
[TBL] [Abstract][Full Text] [Related]
2. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
[TBL] [Abstract][Full Text] [Related]
3. Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
Muñoz L; Martino R; Subirà M; Brunet S; Sureda A; Sierra J
Leuk Lymphoma; 1999 Aug; 34(5-6):585-9. PubMed ID: 10492083
[TBL] [Abstract][Full Text] [Related]
4. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.
Kern WV; Hay B; Kern P; Marre R; Arnold R
Antimicrob Agents Chemother; 1994 Mar; 38(3):465-72. PubMed ID: 8203838
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.
Cruciani M; Malena M; Bosco O; Nardi S; Serpelloni G; Mengoli C
J Clin Oncol; 2003 Nov; 21(22):4127-37. PubMed ID: 14615441
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
8. Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
Bow EJ; Rayner E; Louie TJ
Am J Med; 1988 May; 84(5):847-54. PubMed ID: 3284340
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue.
Meisenberg B; Gollard R; Brehm T; McMillan R; Miller W
Support Care Cancer; 1996 Sep; 4(5):364-9. PubMed ID: 8883230
[TBL] [Abstract][Full Text] [Related]
11. [Infection in patients with neutropenia that undergo an autologous peripheral blood stem cell transplant due to breast cancer].
Palau J; Picón I; Angel Climent M; Martí R; Aznar E; Carmen Sanjuán M; Máiquez J
Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):422-7. PubMed ID: 11709119
[TBL] [Abstract][Full Text] [Related]
12. Tosulfloxacin versus norfloxacin for prevention of infections in chemotherapy-induced neutropenic patients.
Mori S; Ohashi K; Akiyama H; Shoji H; Sato H; Tanikawa S; Sakamaki H; Onozawa Y
Kansenshogaku Zasshi; 1994 Jul; 68(7):872-8. PubMed ID: 8089554
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
[TBL] [Abstract][Full Text] [Related]
14. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
Razonable RR; Litzow MR; Khaliq Y; Piper KE; Rouse MS; Patel R
Clin Infect Dis; 2002 Jun; 34(11):1469-74. PubMed ID: 12015693
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
16. Reduced requirement for antibiotic therapy targeting gram-negative organisms in febrile, neutropenic patients with cancer who are receiving antibacterial chemoprophylaxis with oral quinolones.
Bow EJ; Loewen R; Vaughan D
Clin Infect Dis; 1995 Apr; 20(4):907-12. PubMed ID: 7795093
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
Engels EA; Lau J; Barza M
J Clin Oncol; 1998 Mar; 16(3):1179-87. PubMed ID: 9508206
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
[TBL] [Abstract][Full Text] [Related]
19. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
[TBL] [Abstract][Full Text] [Related]
20. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
Martino P; Micozzi A; Gentile G; Raccah R; Girmenia C; Mandelli F
Clin Infect Dis; 1992 Aug; 15(2):290-4. PubMed ID: 1387806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
